Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The predictive capability of immunohistochemistry and DNA sequencing for determining TP53 functional mutation status: a comparative study of 41 glioblastoma patients

22 Oct 2019

Abstract excerpt

// Aarash K. Roshandel 1 , 2 , * , Christopher M. Busch 2 , 3 , 4 , 5 , * , Jennifer Van Mullekom 6 , Joshua A. Cuoco 4 , 5 , Cara M. Rogers 3 , 4 , 5 , Lisa S. Apfel 3 , 4 , 5 , Eric A. Marvin 3 , 4 , 5 , Harald W. Sontheimer 2 , 3 and Robyn A. Umans 2 1 College of Agriculture and Life Sciences, Virginia Tech, Blacksburg, VA 24061, USA 2 The Fralin Biomedical Research Institute at VTC, Roanoke, VA 24016, USA 3...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related Molecular Pathways
Share to Cancer Research and Treatments
Share to Glioma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31692772
DOI: 10.18632/oncotarget.27252

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The predictive capability of immunohistochemistry and DNA sequencing for determining TP53 functional mutation status: a comparative study of 41 glioblastoma patientsPMID 31692772Read ↗

Revisiting TP53 Mutations and Immunohistochemistry--A Comparative Study in 157 Diffuse Gliomas.Semantic proximity Read ↗

The p53 Pathway in GlioblastomaSemantic proximity Read ↗

The Diagnostic Use of Immunohistochemical Surrogates for Signature Molecular Genetic Alterations in Gliomas.Semantic proximity Read ↗

Elevation of the TP53 isoform Δ133p53β in glioblastomas: an alternative to mutant p53 in promoting tumor development.Semantic proximity Read ↗

A Retrospective Study of the Correlation Between Next-Generation Sequencing and Immunohistochemical Detection of TP53 in Colorectal Cancer.Semantic proximity Read ↗

Correlative assessment of p53 immunostaining patterns and TP53 mutation status by next-generation sequencing in lung adenocarcinoma (LUAD).Semantic proximity Read ↗

A case of glioblastoma harboring non-amplified epidermal growth factor receptor variant III: Critical molecular detection using RNA-based panel analysis.Semantic proximity Read ↗

Detection of TP53 mutations by immunohistochemistry in acute myeloid leukemia varies with interpreter expertise and mutation status.Semantic proximity Read ↗

Real-world Comparison of P53 Immunohistochemistry and TP53 Mutation Analysis Using Next-generation Sequencing.Semantic proximity Read ↗

Multigene profiling to identify alternative treatment options for glioblastoma: a pilot study.Semantic proximity Read ↗

The efficacy of immunohistochemistry in the diagnosis of molecular genetic alterations in central nervous system gliomas: Next-generation sequencing of 212 mutations in 112 patients.Semantic proximity Read ↗

Real-world routine diagnostic molecular analysis for TP53 mutational status is recommended over p53 immunohistochemistry in B-cell lymphomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.